Kyntra Bio, Inc. (KYNB) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Kyntra Bio, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 0.19x | -27.84x | -7.59x | -127.63x | -112.24x | -440.15x |
| P/B Ratio | 7.93x | -5.87x | -10.56x | -1747.54x | 155.65x | 197.35x |
| P/S Ratio | 5.51x | 44.72x | 46.07x | 266.32x | 138.34x | 472.54x |
| Profitability | ||||||
| Gross Margin | 0.0% | 47.5% | 91.5% | 85.6% | -90.9% | 95.0% |
| Operating Margin | -712.7% | -507.8% | -689.5% | -213.9% | -122.6% | -108.8% |
| Net Margin | 2848.6% | -160.6% | -607.3% | -208.7% | -123.3% | -107.4% |
| EBITDA Margin | -712.7% | -480.8% | -652.1% | -201.0% | -141.8% | -93.2% |
| Liquidity | ||||||
| Current Ratio | 3.39x | 1.47x | 1.52x | 1.80x | 2.10x | 4.63x |
| Quick Ratio | 3.26x | 1.45x | 1.33x | 1.65x | 1.96x | 4.53x |
| Leverage | ||||||
| Debt/Equity | 0.00x | -0.40x | -0.83x | -4.19x | 0.48x | 0.09x |
YoY = year-over-year change. Source: FMP..